- Home
- NDMO vs SRDX Comparison
NDMO vs SRDX Comparison
Compare NDMO & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDMO
- SRDX
- Stock Information
- Founded
- NDMO 2019
- SRDX 1979
- Country
- NDMO United States
- SRDX United States
- Employees
- NDMO N/A
- SRDX N/A
- Industry
- NDMO Trusts Except Educational Religious and Charitable
- SRDX Medical/Dental Instruments
- Sector
- NDMO Finance
- SRDX Health Care
- Exchange
- NDMO Nasdaq
- SRDX Nasdaq
- Market Cap
- NDMO 661.7M
- SRDX 562.6M
- IPO Year
- NDMO N/A
- SRDX 1998
- Fundamental
- Price
- NDMO $11.15
- SRDX $38.38
- Analyst Decision
- NDMO
- SRDX Hold
- Analyst Count
- NDMO 0
- SRDX 4
- Target Price
- NDMO N/A
- SRDX $43.00
- AVG Volume (30 Days)
- NDMO 218.6K
- SRDX 228.6K
- Earning Date
- NDMO 01-01-0001
- SRDX 11-06-2024
- Dividend Yield
- NDMO 6.75%
- SRDX N/A
- EPS Growth
- NDMO N/A
- SRDX N/A
- EPS
- NDMO N/A
- SRDX N/A
- Revenue
- NDMO N/A
- SRDX $120,821,000.00
- Revenue This Year
- NDMO N/A
- SRDX N/A
- Revenue Next Year
- NDMO N/A
- SRDX $11.73
- P/E Ratio
- NDMO N/A
- SRDX N/A
- Revenue Growth
- NDMO N/A
- SRDX N/A
- 52 Week Low
- NDMO $8.99
- SRDX $25.17
- 52 Week High
- NDMO $11.24
- SRDX $42.44
- Technical
- Relative Strength Index (RSI)
- NDMO 52.77
- SRDX 41.58
- Support Level
- NDMO $11.07
- SRDX $38.32
- Resistance Level
- NDMO $11.22
- SRDX $38.92
- Average True Range (ATR)
- NDMO 0.10
- SRDX 0.35
- MACD
- NDMO -0.02
- SRDX 0.05
- Stochastic Oscillator
- NDMO 25.00
- SRDX 36.47
About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest
Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. The investment objective of the Fund is to seek total return through income exempt from regular federal income taxes and capital appreciation.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.